Abstract
Significant concerns about the relationship between the use of SSRIs and suicidal risk in adolescents have emerged over the past decade. This presentation will review the extent of the relationship; examine the risks versus the benefits of SSRIs for adolescent depression; discuss the possible explanations for the relationship; and make recommendations for clinical management, public health messaging, and future research.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
